Emanuel Petricoin
Titel
Zitiert von
Zitiert von
Jahr
Use of proteomic patterns in serum to identify ovarian cancer
EF Petricoin III, AM Ardekani, BA Hitt, PJ Levine, VA Fusaro, SM Steinberg, ...
The lancet 359 (9306), 572-577, 2002
41292002
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
SR Hingorani, EF Petricoin III, A Maitra, V Rajapakse, C King, ...
Cancer cell 4 (6), 437-450, 2003
21192003
Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front
CP Paweletz, L Charboneau, VE Bichsel, NL Simone, T Chen, ...
Oncogene 20 (16), 1981-1989, 2001
10802001
Proteomic applications for the early detection of cancer
JD Wulfkuhle, LA Liotta, EF Petricoin
Nature reviews cancer 3 (4), 267-275, 2003
10572003
Serum proteomic patterns for detection of prostate cancer
EF Petricoin III, DK Ornstein, CP Paweletz, A Ardekani, PS Hackett, ...
Journal of the National Cancer Institute 94 (20), 1576-1578, 2002
9082002
Laser-capture microdissection
V Espina, JD Wulfkuhle, VS Calvert, A VanMeter, W Zhou, G Coukos, ...
Nature protocols 1 (2), 586, 2006
7042006
Clinical proteomics: translating benchside promise into bedside reality
EF Petricoin, KC Zoon, EC Kohn, JC Barrett, LA Liotta
Nature reviews Drug discovery 1 (9), 683-695, 2002
6632002
Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance
J Zhou, J Wulfkuhle, H Zhang, P Gu, Y Yang, J Deng, JB Margolick, ...
Proceedings of the National Academy of Sciences 104 (41), 16158-16163, 2007
6352007
Clinical proteomics: written in blood
LA Liotta, M Ferrari, E Petricoin
Nature 425 (6961), 905-905, 2003
6092003
Requirement for MAP kinase (ERK2) activity in interferon alpha-and interferon beta-stimulated gene expression through STAT proteins
M David, E Petricoin, C Benjamin, R Pine, MJ Weber, AC Larner
Science 269 (5231), 1721-1723, 1995
6051995
2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers
G Zhou, H Li, D DeCamp, S Chen, H Shu, Y Gong, M Flaig, JW Gillespie, ...
Molecular & Cellular Proteomics 1 (2), 117-123, 2002
5532002
Molecular profiling of human cancer
L Liotta, E Petricoin
Nature Reviews Genetics 1 (1), 48-56, 2000
5502000
Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays
S Nishizuka, L Charboneau, L Young, S Major, WC Reinhold, M Waltham, ...
Proceedings of the National Academy of Sciences 100 (24), 14229-14234, 2003
5332003
Protein microarrays: meeting analytical challenges for clinical applications
LA Liotta, V Espina, AI Mehta, V Calvert, K Rosenblatt, D Geho, ...
Cancer cell 3 (4), 317-325, 2003
5242003
Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes
CM Bacon, EF Petricoin, JR Ortaldo, RC Rees, AC Larner, JA Johnston, ...
Proceedings of the National Academy of Sciences 92 (16), 7307-7311, 1995
4911995
SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer
EF Petricoin, LA Liotta
Current Opinion in Biotechnology 15 (1), 24-30, 2004
4512004
Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer
MB Jones, H Krutzsch, H Shu, Y Zhao, LA Liotta, EC Kohn, EF Petricoin III
PROTEOMICS: International Edition 2 (1), 76-84, 2002
4182002
Tyrosine phosphorylation of DNA binding proteins by multiple cytokines
AC Larner, M David, GM Feldman, K Igarashi, RH Hackett, DS Webb, ...
Science 261 (5129), 1730-1733, 1993
4081993
Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer
CP Paweletz, B Trock, M Pennanen, T Tsangaris, C Magnant, LA Liotta, ...
Disease markers 17 (4), 301-307, 2001
3852001
The blood peptidome: a higher dimension of information content for cancer biomarker discovery
EF Petricoin, C Belluco, RP Araujo, LA Liotta
Nature Reviews Cancer 6 (12), 961-967, 2006
3682006
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20